NRx Pharmaceuticals

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 Per Share

RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP)  announced that it recently entered into a definitive purchase agreement subject to standard closing conditions with accredited investors to purchase 3,000,000 shares …

NRx Pharmaceuticals Announces Definitive Purchase Agreement for Preferred Shares at $0.40 Per Share Read More